Cost-Effectiveness Analysis of Oral Direct-Acting Antivirals for Chinese Patients with Chronic Hepatitis C
ConclusionsOverall, SOF/VEL and LDV/SOF regimens are more likely to be cost-effective among various subgroups of Chinese patients with CHC.
Source: Applied Health Economics and Health Policy - Category: Health Management Source Type: research
More News: China Health | Cirrhosis | Economics | Health Management | Hepatitis | Hepatitis C | Study